Pleiotropic Effects and Cholesterol-Lowering Therapy

Publisher： Karger

E-ISSN： 1421-9751|112|1|4-12

ISSN： 0008-6312

Source： Cardiology, Vol.112, Iss.1, 2008-06, pp. : 4-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Hemostatic Effects of Cholesterol-Lowering Therapy with Atorvastatin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 2, 2003-11 ,pp. : 84-87

Karger

Access to resources Recommend Favorite

Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy

By Mikhailidis D. P.   Sibbring G. C.   Ballantyne C. M.   Davies G. M.   Catapano A. L.  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 2009-2026

Informa Healthcare

Access to resources Recommend Favorite

Modulation of Adhesion Molecules by Cholesterol‐Lowering Therapy in Mononuclear Cells from Hypercholesterolemic Patients

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 4, 2015-08 ,pp. : 168-176

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cholesterol-lowering drugs and Alzheimer’’s disease

By Eckert Gunter P   Müüller Walter E   Wood W Gibson  

Future Lipidology, Vol. 2, Iss. 4, 2007-08 ,pp. : 423-432

Future Medicine

Access to resources Recommend Favorite

Lipid‐lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic

By  

INTERNAL MEDICINE JOURNAL, Vol. 48, Iss. 2, 2018-02 ,pp. : 201-204

John Wiley & Sons Inc

Access to resources Recommend Favorite